Back to All
Group

Webinar: Personalized Medicine Forecast 2016

28 January, 2016

A forecast for the industry raises some interesting points. Will there be 50 per cent more targeted therapy launches in 2016? Are labs becoming the key pharma launch partners? Are payer value models finally get some traction? And how will companion and complementary diagnostics be defined? Listen to this webinar to learn:

  • Insights on the latest trends in targeted therapies
  • Best practices for your companion and complementary diagnostics launch
  • What you should be thinking about for your successful launch

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny